UBS Group
NURE icon

UBS Group’s Nuveen Short-Term REIT ETF NURE Stock Holding History

UBS Group’s Portfolio NURE Stock Details NURE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29K Buy
896
+148
+20% +$4.49K ﹤0.01% 7917
2026
Q1 		$20.3K Buy
748
+377
+102% +$10.8K ﹤0.01% 7917
2025
Q4 		$10.4K Sell
371
-11,102
-97% -$312K ﹤0.01% 8219
2025
Q3 		$330K Sell
11,473
-1,974
-15% -$58K ﹤0.01% 6370
2025
Q2 		$399K Buy
13,447
+13,131
+4,155% +$392K ﹤0.01% 6200
2025
Q1 		$9.88K Buy
+316
New +$9.94K ﹤0.01% 8669
2024
Q4 		– Sell
-70
Closed -$2.37K – 10252
2024
Q3 		$2.37K Sell
70
-25
-26% -$819 ﹤0.01% 8444
2024
Q2 		$2.95K Sell
95
-67
-41% -$2.02K ﹤0.01% 8277
2024
Q1 		$4.96K Sell
162
-1,196
-88% -$36K ﹤0.01% 7572
2023
Q4 		$41.9K Sell
1,358
-1,073
-44% -$29.9K ﹤0.01% 6651
2023
Q3 		$66K Buy
2,431
+1,419
+140% +$41.8K ﹤0.01% 6110
2023
Q2 		$30.8K Sell
1,012
-3,052
-75% -$91.5K ﹤0.01% 6708
2023
Q1 		$121K Buy
4,064
+3,391
+504% +$102K ﹤0.01% 5772
2022
Q4 		$19.1K Sell
673
-2,333
-78% -$68.9K ﹤0.01% 7695
2022
Q3 		$89K Buy
+3,006
New +$101K ﹤0.01% 5807
2021
Q4 		– Sell
-84
Closed -$3K – 10557
2021
Q3 		$3K Sell
84
-2,410
-97% -$86.8K ﹤0.01% 8825
2021
Q2 		$85K Buy
2,494
+2,248
+914% +$73.6K ﹤0.01% 6003
2021
Q1 		$7K Sell
246
-3,726
-94% -$106K ﹤0.01% 8158
2020
Q4 		$107K Buy
3,972
+2,642
+199% +$67.3K ﹤0.01% 5643
2020
Q3 		$31K Buy
1,330
+8
+0.6% +$185 ﹤0.01% 5971
2020
Q2 		$30K Sell
1,322
-373
-22% -$8.37K ﹤0.01% 6272
2020
Q1 		$36K Buy
+1,695
New +$47.3K ﹤0.01% 6087
2019
Q1 		– Sell
-1,814
Closed -$45K – 8017
2018
Q4 		$45K Buy
1,814
+914
+102% +$24.2K ﹤0.01% 6188
2018
Q3 		$25K Buy
900
+864
+2,400% +$23.8K ﹤0.01% 6667
2018
Q2 		$1K Hold
36
– – ﹤0.01% 7825
2018
Q1 		$1K Buy
+36
New +$894 ﹤0.01% 7648
2017
Q3 		– Sell
-40
Closed -$1K – 7906
2017
Q2 		$1K Buy
+40
New +$1.03K ﹤0.01% 7506

Other funds holding NURE

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
CWM
Cornerstone Wealth Management St. Peters, Missouri $2.33B AUM 25.21% 1-Year Est. Return
KW
KWB Wealth Redlands, California $1.17B AUM 18.92% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
SWTS
Stonehaven Wealth & Tax Solutions Appleton, Wisconsin $125M AUM 18.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

UBS Group's NURE Position: Q2 2026 in Review

UBS Group increased its Nuveen Short-Term REIT ETF (NURE) stake by 20% in Q2 2026, buying an estimated $4.49K and bringing the position to 896 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #7917.

UBS Group first reported a position in NURE in Q2 2017 and has held it in 27 quarters since. The position peaked at $399K in Q2 2025. 31 funds tracked by Wall St. Rank hold NURE as of Q2 2026.

  • UBS Group held 896 shares of Nuveen Short-Term REIT ETF worth $29K as of Q2 2026.
  • UBS Group bought 148 Nuveen Short-Term REIT ETF shares in Q2 2026, an estimated $4.49K.
  • Nuveen Short-Term REIT ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7917 holding.
  • UBS Group first reported a position in Nuveen Short-Term REIT ETF in Q2 2017 and has held it in 27 quarters since.
  • UBS Group's Nuveen Short-Term REIT ETF position peaked at $399K in Q2 2025.
  • 31 funds tracked by Wall St. Rank held Nuveen Short-Term REIT ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.